ICAM1 and type 1 diabetes mellitus: Moreover, the treatment with an antibody neutralizing vascular cell adhesion molecule-1 (VCAM-1) delayed the onset of disease, whereas blocking antibody against intercellular adhesion molecule-1 (ICAM-1) had only a marginal effect on the onset of T1D [30].